Skip to main content
Top
Published in: BMC Infectious Diseases 1/2012

Open Access 01-12-2012 | Research article

Treatment of Haemophilus bacteremia with benzylpenicillin is associated with increased (30-day) mortality

Authors: Sara Thønnings, Christian Østergaard

Published in: BMC Infectious Diseases | Issue 1/2012

Login to get access

Abstract

Background

Optimal antibiotic treatment strategies of Haemophilus infections are still needed. Therefore, 30-day case fatality rate (CFR) of Haemophilus bacteremia and efficacy of various antibiotic treatment regimes were studied.

Methods

All episodes of Haemophilus bacteremia in the former Copenhagen County during the period 2000-9 were included in the study. Clinical and biochemical findings and outcome were collected retrospectively from medical records.

Results

105 consecutive episodes were identified (median age: 69 years, with only 4 children <16 years), 72% were due to non-typeable -, 16% to typeable H. influenzae, and 11% to other Haemophilus species. Pneumonia was the most common primary focus (in 48%), and 58% of the patients had Charlson comorbidity index > 1. Definitive antibiotic therapy was in 26 cases benzylpenicillin, in 12 cases aminopenicillins, in 50 cases cefuroxime and in 16 cases broadspectrum antibiotics, whereas 1 palliative case died without start of therapy. Whereas the use of broadspectrum antibiotics was related to the severity of the disease (admittance to ICU, need for assisted ventilation or hemodialysis, septic shock), no significant difference in clinical features was demonstrated for therapy with benzylpenicillin, aminopenicillin or cefuroxime, except benzylpenicillin was rarely administered to immunosuppressed patients. The CFR was 22% (23/105). The choice of empiric antibiotic therapy was not significantly associated with mortality (adequate vs. inadequate treatment: 23% (21/93) vs. 17% (2/12), respectively, P > 0.05). In contrast, definite antibiotic therapy with cefuroxime or aminopenicillins resulted in a significantly lower CFR than treatment with benzylpenicillin (12% (6/50) or 0% (0/12) vs. 39% (10/26), respectively, Log rank test P < 0.02). When adjustments were made for other identified risk factors in bivariate logistic regression analysis, treatment with cefuroxime was still were found to be associated with a significantly lower CFR than for benzylpenicillin: OR: 0.21 (0.06-0.69), P = 0.01 (hospital-acquired bacteremia), OR: 0.27 (0.08-0.91), P = 0.04 (polymicrobial episodes), OR: 0.16 (0.04-0.59), P = 0.006 (admittance at intensive care unit), OR: 0.22 (0.06-0.82), P = 0.02 (alcohol abuse), OR: 0.15 (0.04-0.60), P = 0.008 (altered mental state), OR: 0.22 (0.07-0.71), P = 0.01 (temperature < 38 °C), OR: 0.23 (0.07-0.79), P = 0.02 (septic shock), OR: 0.21 (0.06-0.69), P = 0.01 (mechanical ventilation).

Conclusion

Our results suggest that, after susceptibility testing, cefuroxime or aminopenicillins are preferable to benzylpenicillins as definitive therapy for Haemophilus bacteremia.
Appendix
Available only for authorised users
Literature
1.
go back to reference Laupland KB, Schonheyder HC, Ostergaard C, Knudsen JD, Valiquette L, Galbraith J, Kennedy KJ, Gradel KO: Epidemiology of Haemophilus influenzae bacteremia: a multi-national population-based assessment. J Infect. 2011, 62: 142-148. 10.1016/j.jinf.2010.11.009.CrossRefPubMed Laupland KB, Schonheyder HC, Ostergaard C, Knudsen JD, Valiquette L, Galbraith J, Kennedy KJ, Gradel KO: Epidemiology of Haemophilus influenzae bacteremia: a multi-national population-based assessment. J Infect. 2011, 62: 142-148. 10.1016/j.jinf.2010.11.009.CrossRefPubMed
2.
go back to reference Peltola H, Anttila M, Renkonen OV: Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group [see comments]. Lancet. 1989, 1: 1281-1287.CrossRefPubMed Peltola H, Anttila M, Renkonen OV: Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group [see comments]. Lancet. 1989, 1: 1281-1287.CrossRefPubMed
3.
go back to reference Schaad UB, Suter S, Gianella Borradori A, Pfenninger J, Auckenthaler R, Bernath O, Cheseaux JJ, Wedgwood J: A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. N Engl J Med. 1990, 322: 141-147. 10.1056/NEJM199001183220301.CrossRefPubMed Schaad UB, Suter S, Gianella Borradori A, Pfenninger J, Auckenthaler R, Bernath O, Cheseaux JJ, Wedgwood J: A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. N Engl J Med. 1990, 322: 141-147. 10.1056/NEJM199001183220301.CrossRefPubMed
4.
go back to reference Westh H, Frimodt-Moller N, Gutschik E, Bangsborg J: Killing curve activity of ciprofloxacin is comparable to synergistic effect of beta-lactam-tobramycin combinations against Haemophilus species endocarditis strains. APMIS. 1992, 100: 856-860. 10.1111/j.1699-0463.1992.tb04011.x.CrossRefPubMed Westh H, Frimodt-Moller N, Gutschik E, Bangsborg J: Killing curve activity of ciprofloxacin is comparable to synergistic effect of beta-lactam-tobramycin combinations against Haemophilus species endocarditis strains. APMIS. 1992, 100: 856-860. 10.1111/j.1699-0463.1992.tb04011.x.CrossRefPubMed
5.
6.
go back to reference Bamberger DM, Foxworth JW, Bridwell DL, Shain CS, Gerding DN: Extravascular antimicrobial distribution and respective blood and urine concentrations in humans. Antibiotics in Laboratory Medicine. Fifth Edition edition. Edited by: Lorian V. 2005, , , 719-809. Bamberger DM, Foxworth JW, Bridwell DL, Shain CS, Gerding DN: Extravascular antimicrobial distribution and respective blood and urine concentrations in humans. Antibiotics in Laboratory Medicine. Fifth Edition edition. Edited by: Lorian V. 2005, , , 719-809.
7.
go back to reference Mayo JB, McCarthy LR: Antimicrobial susceptibility of Haemophilus parainfluenzae. Antimicrob Agents Chemother. 1977, 11: 844-847. 10.1128/AAC.11.5.844.CrossRefPubMedPubMedCentral Mayo JB, McCarthy LR: Antimicrobial susceptibility of Haemophilus parainfluenzae. Antimicrob Agents Chemother. 1977, 11: 844-847. 10.1128/AAC.11.5.844.CrossRefPubMedPubMedCentral
8.
go back to reference Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR: A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996, 49: 1373-1379. 10.1016/S0895-4356(96)00236-3.CrossRefPubMed Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR: A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996, 49: 1373-1379. 10.1016/S0895-4356(96)00236-3.CrossRefPubMed
9.
go back to reference McVernon J, Trotter CL, Slack MP, Ramsay ME: Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study. BMJ. 2004, 329: 655-658. 10.1136/bmj.329.7467.655.CrossRefPubMedPubMedCentral McVernon J, Trotter CL, Slack MP, Ramsay ME: Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study. BMJ. 2004, 329: 655-658. 10.1136/bmj.329.7467.655.CrossRefPubMedPubMedCentral
10.
go back to reference Ulanova M, Tsang RS: Invasive Haemophilus influenzae disease: changing epidemiology and host-parasite interactions in the 21st century. Infect Genet Evol. 2009, 9: 594-605. 10.1016/j.meegid.2009.03.001.CrossRefPubMed Ulanova M, Tsang RS: Invasive Haemophilus influenzae disease: changing epidemiology and host-parasite interactions in the 21st century. Infect Genet Evol. 2009, 9: 594-605. 10.1016/j.meegid.2009.03.001.CrossRefPubMed
11.
go back to reference Adam HJ, Richardson SE, Jamieson FB, Rawte P, Low DE, Fisman DN: Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination. Vaccine. 2010, 28: 4073-4078. 10.1016/j.vaccine.2010.03.075.CrossRefPubMed Adam HJ, Richardson SE, Jamieson FB, Rawte P, Low DE, Fisman DN: Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination. Vaccine. 2010, 28: 4073-4078. 10.1016/j.vaccine.2010.03.075.CrossRefPubMed
12.
go back to reference Bisgard KM, Kao A, Leake J, Strebel PM, Perkins BA, Wharton M: Haemophilus influenzae invasive disease in the United States, 1994–1995: near disappearance of a vaccine-preventable childhood disease. Emerg Infect Dis. 1998, 4: 229-237. 10.3201/eid0402.980210.CrossRefPubMedPubMedCentral Bisgard KM, Kao A, Leake J, Strebel PM, Perkins BA, Wharton M: Haemophilus influenzae invasive disease in the United States, 1994–1995: near disappearance of a vaccine-preventable childhood disease. Emerg Infect Dis. 1998, 4: 229-237. 10.3201/eid0402.980210.CrossRefPubMedPubMedCentral
13.
go back to reference Garpenholt O, Hugosson S, Fredlund H, Giesecke J, Olcen P: Invasive disease due to Haemophilus influenzae type b during the first six years of general vaccination of Swedish children. Acta Paediatr. 2000, 89: 471-474. 10.1080/080352500750028212.CrossRefPubMed Garpenholt O, Hugosson S, Fredlund H, Giesecke J, Olcen P: Invasive disease due to Haemophilus influenzae type b during the first six years of general vaccination of Swedish children. Acta Paediatr. 2000, 89: 471-474. 10.1080/080352500750028212.CrossRefPubMed
14.
go back to reference Campos J, Hernando M, Roman F, Perez-Vazquez M, Aracil B, Oteo J, Lazaro E, de Abajo F: Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H. influenzae type b. J Clin Microbiol. 2004, 42: 524-529. 10.1128/JCM.42.2.524-529.2004.CrossRefPubMedPubMedCentral Campos J, Hernando M, Roman F, Perez-Vazquez M, Aracil B, Oteo J, Lazaro E, de Abajo F: Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H. influenzae type b. J Clin Microbiol. 2004, 42: 524-529. 10.1128/JCM.42.2.524-529.2004.CrossRefPubMedPubMedCentral
15.
go back to reference Scheifele DW, Bettinger JA, Halperin SA, Law B, Bortolussi R: Ongoing control of Haemophilus influenzae type B infections in Canadian children, 2004–2007. Pediatr Infect Dis J. 2008, 27: 755-757. 10.1097/INF.0b013e31816fc339.CrossRefPubMed Scheifele DW, Bettinger JA, Halperin SA, Law B, Bortolussi R: Ongoing control of Haemophilus influenzae type B infections in Canadian children, 2004–2007. Pediatr Infect Dis J. 2008, 27: 755-757. 10.1097/INF.0b013e31816fc339.CrossRefPubMed
16.
go back to reference Peltola H, Aavitsland P, Hansen KG, Jonsdottir KE, Nokleby H, Romanus V: Perspective: a five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia. J Infect Dis. 1999, 179: 223-229. 10.1086/314535.CrossRefPubMed Peltola H, Aavitsland P, Hansen KG, Jonsdottir KE, Nokleby H, Romanus V: Perspective: a five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia. J Infect Dis. 1999, 179: 223-229. 10.1086/314535.CrossRefPubMed
17.
go back to reference Farley MM, Stephens DS, Brachman PS, Harvey RC, Smith JD, Wenger JD: Invasive Haemophilus influenzae disease in adults. A prospective, population-based surveillance. CDC Meningitis Surveillance Group. Ann Intern Med. 1992, 116: 806-812.CrossRefPubMed Farley MM, Stephens DS, Brachman PS, Harvey RC, Smith JD, Wenger JD: Invasive Haemophilus influenzae disease in adults. A prospective, population-based surveillance. CDC Meningitis Surveillance Group. Ann Intern Med. 1992, 116: 806-812.CrossRefPubMed
18.
go back to reference Kostman JR, Sherry BL, Fligner CL, Egaas S, Sheeran P, Baken L, Bauwens JE, Clausen C, Sherer DM, Plorde JJ, et al: Invasive Haemophilus influenzae infections in older children and adults in Seattle. Clin Infect Dis. 1993, 17: 389-396. 10.1093/clinids/17.3.389.CrossRefPubMed Kostman JR, Sherry BL, Fligner CL, Egaas S, Sheeran P, Baken L, Bauwens JE, Clausen C, Sherer DM, Plorde JJ, et al: Invasive Haemophilus influenzae infections in older children and adults in Seattle. Clin Infect Dis. 1993, 17: 389-396. 10.1093/clinids/17.3.389.CrossRefPubMed
19.
go back to reference Sarangi J, Cartwright K, Stuart J, Brookes S, Morris R, Slack M: Invasive Haemophilus influenzae disease in adults. Epidemiol Infect. 2000, 124: 441-447. 10.1017/S0950268899003611.CrossRefPubMedPubMedCentral Sarangi J, Cartwright K, Stuart J, Brookes S, Morris R, Slack M: Invasive Haemophilus influenzae disease in adults. Epidemiol Infect. 2000, 124: 441-447. 10.1017/S0950268899003611.CrossRefPubMedPubMedCentral
20.
go back to reference Ladhani S, Slack MP, Heath PT, von Gottberg A, Chandra M, Ramsay ME: Invasive Haemophilus influenzae Disease, Europe, 1996–2006. Emerg Infect Dis. 2010, 16: 455-463.CrossRefPubMedPubMedCentral Ladhani S, Slack MP, Heath PT, von Gottberg A, Chandra M, Ramsay ME: Invasive Haemophilus influenzae Disease, Europe, 1996–2006. Emerg Infect Dis. 2010, 16: 455-463.CrossRefPubMedPubMedCentral
21.
go back to reference Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH: Manual of clinical microbiology. 1999, American Society for Microbiology, Washington D.C. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH: Manual of clinical microbiology. 1999, American Society for Microbiology, Washington D.C.
22.
go back to reference Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988, 16: 128-140. 10.1016/0196-6553(88)90053-3.CrossRefPubMed Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988, 16: 128-140. 10.1016/0196-6553(88)90053-3.CrossRefPubMed
23.
go back to reference Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, et al: Health care–associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002, 137: 791-797.CrossRefPubMed Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, et al: Health care–associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002, 137: 791-797.CrossRefPubMed
24.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40: 373-383. 10.1016/0021-9681(87)90171-8.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40: 373-383. 10.1016/0021-9681(87)90171-8.CrossRefPubMed
Metadata
Title
Treatment of Haemophilus bacteremia with benzylpenicillin is associated with increased (30-day) mortality
Authors
Sara Thønnings
Christian Østergaard
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2012
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-12-153

Other articles of this Issue 1/2012

BMC Infectious Diseases 1/2012 Go to the issue